88 related articles for article (PubMed ID: 18768494)
1. Prognostic value of signal transducers and activators of transcription 3 in breast cancer.
Sheen-Chen SM; Huang CC; Tang RP; Chou FF; Eng HL
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2286-90. PubMed ID: 18768494
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CC; Tang RP; Yang CH; Chou FF; Eng HL
Anticancer Res; 2007; 27(4B):2481-6. PubMed ID: 17695542
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP
Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Zhang H; Huang CC; Tang RP
Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
[TBL] [Abstract][Full Text] [Related]
7. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of fatty acid-CoA ligase 4 in breast cancer.
Tsai CH; Sheen-Chen SM; Huang CY; Chen YJ; Chi SY; Ko SF; Lee YW; Liang JL; Hsu HW; Huang EY; Chen HC; Huang CC; Rau KM; Tang RP
Anticancer Res; 2014 Mar; 34(3):1239-43. PubMed ID: 24596366
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays.
Sheen-Chen SM; Huang CY; Chan YC; Tsai CH; Chi SY; Wu SC; Huang CC; Tang RP; Eng HL; Ko SF; Lee YW; Liang JL; Huang EY; Chen HC; Rau KM
Anticancer Res; 2013 Mar; 33(3):1169-73. PubMed ID: 23482798
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of prognostic value of death-associated protein kinase 1 in breast cancer.
Chou SE; Huang CY; Sheen-Chen SM; Liu YW; Tsai CH; Lin YH; Huang CC; Tang RP
Anticancer Res; 2011 Oct; 31(10):3633-6. PubMed ID: 21965790
[TBL] [Abstract][Full Text] [Related]
12. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
Alvarez JV; Febbo PG; Ramaswamy S; Loda M; Richardson A; Frank DA
Cancer Res; 2005 Jun; 65(12):5054-62. PubMed ID: 15958548
[TBL] [Abstract][Full Text] [Related]
13. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.
Rakha EA; El-Sayed ME; Lee AH; Elston CW; Grainge MJ; Hodi Z; Blamey RW; Ellis IO
J Clin Oncol; 2008 Jul; 26(19):3153-8. PubMed ID: 18490649
[TBL] [Abstract][Full Text] [Related]
15. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
16. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary metastases of breast cancer. When is resection indicated?
Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
[TBL] [Abstract][Full Text] [Related]
18. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients.
Wiesner FG; Magener A; Fasching PA; Wesse J; Bani MR; Rauh C; Jud S; Schrauder M; Loehberg CR; Beckmann MW; Hartmann A; Lux MP
Breast; 2009 Apr; 18(2):135-41. PubMed ID: 19342238
[TBL] [Abstract][Full Text] [Related]
20. Cortactin in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Liu YY; Huang CC; Tang RP
Anticancer Res; 2011 Jan; 31(1):293-7. PubMed ID: 21273613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
